{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T13:17:58Z","timestamp":1793452678983,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2021,10,11]],"date-time":"2021-10-11T00:00:00Z","timestamp":1633910400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["1F31AG058439"],"award-info":[{"award-number":["1F31AG058439"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["AG057683"],"award-info":[{"award-number":["AG057683"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["1F31AG057150"],"award-info":[{"award-number":["1F31AG057150"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["AG057683"],"award-info":[{"award-number":["AG057683"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging","doi-asserted-by":"publisher","award":["AG048017"],"award-info":[{"award-number":["AG048017"]}],"id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"U.S. Department of Health & Human Services | NIH | National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["TR001743"],"award-info":[{"award-number":["TR001743"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000066","name":"U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences","doi-asserted-by":"publisher","award":["ES028047"],"award-info":[{"award-number":["ES028047"]}],"id":[{"id":"10.13039\/100000066","id-type":"DOI","asserted-by":"publisher"}]},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"},{"name":"U.S. Department of Health & Human Services | NIH | National Institute on Aging"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Aging"],"DOI":"10.1038\/s43587-021-00122-7","type":"journal-article","created":{"date-parts":[[2021,10,12]],"date-time":"2021-10-12T05:20:46Z","timestamp":1634016046000},"page":"932-947","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":113,"title":["Experimental and real-world evidence supporting the computational repurposing of bumetanide for APOE4-related Alzheimer\u2019s disease"],"prefix":"10.1038","volume":"1","author":[{"given":"Alice","family":"Taubes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Phil","family":"Nova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly A.","family":"Zalocusky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2212-5472","authenticated-orcid":false,"given":"Idit","family":"Kosti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mesude","family":"Bicak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7164-8312","authenticated-orcid":false,"given":"Misha Y.","family":"Zilberter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanxia","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seo Yeon","family":"Yoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7393-5120","authenticated-orcid":false,"given":"Tomiko","family":"Oskotsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Pineda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8858-874X","authenticated-orcid":false,"given":"Bin","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily A.","family":"Aery Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7966-1527","authenticated-orcid":false,"given":"Krishna","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Grone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maureen E.","family":"Balestra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fayzan","family":"Chaudhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ishan","family":"Paranjpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"De Freitas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Koutsodendris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuo","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celine","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4515-8090","authenticated-orcid":false,"given":"Benjamin S.","family":"Glicksberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7246-6083","authenticated-orcid":false,"given":"Marina","family":"Sirota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5871-4589","authenticated-orcid":false,"given":"Yadong","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,10,11]]},"reference":[{"key":"122_CR1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.neuron.2011.01.002","volume":"69","author":"TE Golde","year":"2011","unstructured":"Golde, T. E., Schneider, L. S. & Koo, E. H. Anti-A\u03b2 therapeutics in Alzheimer\u2019s disease: the need for a paradigm shift. Neuron 69, 203\u2013213 (2011).","journal-title":"Neuron"},{"key":"122_CR2","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.cell.2012.02.040","volume":"148","author":"Y Huang","year":"2012","unstructured":"Huang, Y. & Mucke, L. Alzheimer mechanisms and therapeutic strategies. Cell 148, 1204\u20131222 (2012).","journal-title":"Cell"},{"key":"122_CR3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","volume":"9","author":"CC Liu","year":"2013","unstructured":"Liu, C. C., Kanekiyo, T., Xu, H. & Bu, G. Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy. Nat. Rev. Neurol. 9, 106\u2013118 (2013).","journal-title":"Nat. Rev. Neurol."},{"key":"122_CR4","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(10)70325-2","volume":"10","author":"PB Verghese","year":"2011","unstructured":"Verghese, P. B., Castellano, J. M. & Holtzman, D. M. Apolipoprotein E in Alzheimer\u2019s disease and other neurological disorders. Lancet Neurol. 10, 241\u2013252 (2011).","journal-title":"Lancet Neurol."},{"key":"122_CR5","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.neuron.2012.11.020","volume":"76","author":"RW Mahley","year":"2012","unstructured":"Mahley, R. W. & Huang, Y. Apolipoprotein E sets the stage: response to injury triggers neuropathology. Neuron 76, 871\u2013885 (2012).","journal-title":"Neuron"},{"key":"122_CR6","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.8346443","volume":"261","author":"EH Corder","year":"1993","unstructured":"Corder, E. H. et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer\u2019s disease in late onset families. Science 261, 921\u2013923 (1993).","journal-title":"Science"},{"key":"122_CR7","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1056\/NEJMc051856","volume":"353","author":"EE Barnes","year":"2005","unstructured":"Barnes, E. E. & Yaffe, K. Vitamin E and donepezil for the treatment of mild cognitive impairment. N. Engl. J. Med. 353, 951\u2013952 (2005).","journal-title":"N. Engl. J. Med."},{"key":"122_CR8","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1038\/npp.2009.214","volume":"35","author":"NL Marchant","year":"2010","unstructured":"Marchant, N. L., King, S. L., Tabet, N. & Rusted, J. M. Positive effects of cholinergic stimulation favor young APOE \u03b54 carriers. Neuropsychopharmacology 35, 1090\u20131096 (2010).","journal-title":"Neuropsychopharmacology"},{"key":"122_CR9","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1056\/NEJMoa1304839","volume":"370","author":"S Salloway","year":"2014","unstructured":"Salloway, S. et al. Two phase 3 trials of bapineuzumab in mild-to-moderate Alzheimer\u2019s disease. N. Engl. J. Med. 370, 322\u2013333 (2014).","journal-title":"N. Engl. J. Med."},{"key":"122_CR10","doi-asserted-by":"crossref","first-page":"e1002503","DOI":"10.1371\/journal.pcbi.1002503","volume":"8","author":"F Cheng","year":"2012","unstructured":"Cheng, F. et al. Prediction of drug\u2013target interactions and drug repositioning via network-based inference. PLoS Comput. Biol. 8, e1002503 (2012).","journal-title":"PLoS Comput. Biol."},{"key":"122_CR11","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.pharmthera.2013.01.016","volume":"138","author":"P Csermely","year":"2013","unstructured":"Csermely, P., Korcsmaros, T., Kiss, H. J., London, G. & Nussinov, R. Structure and dynamics of molecular network: a novel paradigm of drug discovery: a comprehensive review. Pharmacol. Ther. 138, 333\u2013408 (2013).","journal-title":"Pharmacol. Ther."},{"key":"122_CR12","doi-asserted-by":"crossref","first-page":"96ra77","DOI":"10.1126\/scitranslmed.3001318","volume":"3","author":"M Sirota","year":"2011","unstructured":"Sirota, M. et al. Discovery and preclinical validation of drug indications using compendia of public gene expression data. Sci. Transl. Med. 3, 96ra77 (2011).","journal-title":"Sci. Transl. Med."},{"key":"122_CR13","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1053\/j.gastro.2017.02.039","volume":"152","author":"B Chen","year":"2017","unstructured":"Chen, B. et al. Computational discovery of niclosamide ethanolamine, a repurposed drug candidate that reduces growth of hepatocellular carcinoma cells in vitro and in mice by inhibiting cell division cycle 37 signaling. Gastroenterology 152, 2022\u20132036 (2017).","journal-title":"Gastroenterology"},{"key":"122_CR14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/cpt.318","volume":"99","author":"B Chen","year":"2016","unstructured":"Chen, B. & Butte, A. J. Leveraging big data to transform target selection and drug discovery. Clin. Pharmacol. Ther. 99, 285\u2013297 (2016).","journal-title":"Clin. Pharmacol. Ther."},{"key":"122_CR15","first-page":"22","volume":"2016","author":"X Cai","year":"2016","unstructured":"Cai, X., Chen, Y., Gao, Z. & Xu, R. Explore small molecule-induced genome-wide transcriptional profiles for novel inflammatory bowel disease drug. AMIA Jt Summits Transl. Sci. Proc. 2016, 22\u201331 (2016).","journal-title":"AMIA Jt Summits Transl. Sci. Proc."},{"key":"122_CR16","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1126\/science.1132939","volume":"313","author":"J Lamb","year":"2006","unstructured":"Lamb, J. et al. The Connectivity Map: using gene-expression signatures to connect small molecules, genes, and disease. Science 313, 1929\u20131935 (2006).","journal-title":"Science"},{"key":"122_CR17","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ajhg.2009.03.011","volume":"84","author":"JA Webster","year":"2009","unstructured":"Webster, J. A. et al. Genetic control of human brain transcript expression in Alzheimer disease. Am. J. Hum. Genet. 84, 445\u2013458 (2009).","journal-title":"Am. J. Hum. Genet."},{"key":"122_CR18","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.1997.03550160069041","volume":"278","author":"LA Farrer","year":"1997","unstructured":"Farrer, L. A. et al. Effects of age, sex, and ethnicity on the association between apolipoprotein E genotype and Alzheimer disease. A meta-analysis. JAMA 278, 1349\u20131356 (1997).","journal-title":"JAMA"},{"key":"122_CR19","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie, M. E. et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47 (2015).","journal-title":"Nucleic Acids Res."},{"key":"122_CR20","volume":"8","author":"B Chen","year":"2017","unstructured":"Chen, B. et al. Reversal of cancer gene expression correlates with drug efficacy and reveals therapeutic targets. Nat. Commun. 8, 16022 (2017).","journal-title":"Nat. Commun."},{"key":"122_CR21","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s40263-019-00607-5","volume":"33","author":"Z Gharaylou","year":"2019","unstructured":"Gharaylou, Z. et al. A preliminary study evaluating the safety and efficacy of bumetanide, an NKCC1 inhibitor, in patients with drug-resistant epilepsy. CNS Drugs 33, 283\u2013291 (2019).","journal-title":"CNS Drugs"},{"key":"122_CR22","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3389\/fnmol.2019.00012","volume":"12","author":"E Goubert","year":"2019","unstructured":"Goubert, E. et al. Bumetanide prevents brain trauma-induced depressive-like behavior. Front. Mol. Neurosci. 12, 12 (2019).","journal-title":"Front. Mol. Neurosci."},{"key":"122_CR23","doi-asserted-by":"crossref","DOI":"10.1038\/tp.2012.124","volume":"2","author":"E Lemonnier","year":"2012","unstructured":"Lemonnier, E. et al. A randomised controlled trial of bumetanide in the treatment of autism in children. Transl. Psychiatry 2, e202 (2012).","journal-title":"Transl. Psychiatry"},{"key":"122_CR24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1097\/WNF.0000000000000136","volume":"39","author":"E Lemonnier","year":"2016","unstructured":"Lemonnier, E., Lazartigues, A. & Ben-Ari, Y. Treating schizophrenia with the diuretic bumetanide: a case report. Clin. Neuropharmacol. 39, 115\u2013117 (2016).","journal-title":"Clin. Neuropharmacol."},{"key":"122_CR25","volume":"7","author":"E Lemonnier","year":"2017","unstructured":"Lemonnier, E. et al. Effects of bumetanide on neurobehavioral function in children and adolescents with autism spectrum disorders. Transl. Psychiatry 7, e1056 (2017).","journal-title":"Transl. Psychiatry"},{"key":"122_CR26","doi-asserted-by":"crossref","first-page":"408","DOI":"10.32598\/bcn.9.6.408","volume":"9","author":"R Rahmanzadeh","year":"2018","unstructured":"Rahmanzadeh, R. et al. Effect of co-administration of bumetanide and phenobarbital on seizure attacks in temporal lobe epilepsy. Basic Clin. Neurosci. 9, 408\u2013416 (2018).","journal-title":"Basic Clin. Neurosci."},{"key":"122_CR27","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/epi.13270","volume":"57","author":"S Sivakumaran","year":"2016","unstructured":"Sivakumaran, S. & Maguire, J. Bumetanide reduces seizure progression and the development of pharmacoresistant status epilepticus. Epilepsia 57, 222\u2013232 (2016).","journal-title":"Epilepsia"},{"key":"122_CR28","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.neuron.2020.02.034","volume":"106","author":"N Zhao","year":"2020","unstructured":"Zhao, N. et al. Alzheimer\u2019s risk factors age, APOE genotype, and sex drive distinct molecular pathways. Neuron 106, 727\u2013742 (2020).","journal-title":"Neuron"},{"key":"122_CR29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13024-019-0324-6","volume":"14","author":"R Najm","year":"2019","unstructured":"Najm, R., Jones, E. A. & Huang, Y. Apolipoprotein E4, inhibitory network dysfunction, and Alzheimer\u2019s disease. Mol. Neurodegener. 14, 24 (2019).","journal-title":"Mol. Neurodegener."},{"key":"122_CR30","doi-asserted-by":"crossref","DOI":"10.1038\/srep38242","volume":"6","author":"G Milior","year":"2016","unstructured":"Milior, G. et al. Electrophysiological properties of CA1 pyramidal neurons along the longitudinal axis of the mouse hippocampus. Sci. Rep. 6, 38242 (2016).","journal-title":"Sci. Rep."},{"key":"122_CR31","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/361031a0","volume":"361","author":"TV Bliss","year":"1993","unstructured":"Bliss, T. V. & Collingridge, G. L. A synaptic model of memory: long-term potentiation in the hippocampus. Nature 361, 31\u201339 (1993).","journal-title":"Nature"},{"key":"122_CR32","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1126\/science.1074069","volume":"298","author":"DJ Selkoe","year":"2002","unstructured":"Selkoe, D. J. Alzheimer\u2019s disease is a synaptic failure. Science 298, 789\u2013791 (2002).","journal-title":"Science"},{"key":"122_CR33","doi-asserted-by":"crossref","first-page":"13707","DOI":"10.1523\/JNEUROSCI.4040-10.2010","volume":"30","author":"Y Andrews-Zwilling","year":"2010","unstructured":"Andrews-Zwilling, Y. et al. Apolipoprotein E4 causes age- and tau-dependent impairment of GABAergic interneurons, leading to learning and memory deficits in mice. J. Neurosci. 30, 13707\u201313717 (2010).","journal-title":"J. Neurosci."},{"key":"122_CR34","doi-asserted-by":"crossref","first-page":"e53569","DOI":"10.1371\/journal.pone.0053569","volume":"7","author":"L Leung","year":"2012","unstructured":"Leung, L. et al. Apolipoprotein E4 causes age- and sex-dependent impairments of hilar GABAergic interneurons and learning and memory deficits in mice. PLoS ONE 7, e53569 (2012).","journal-title":"PLoS ONE"},{"key":"122_CR35","doi-asserted-by":"crossref","first-page":"14069","DOI":"10.1523\/JNEUROSCI.2281-14.2014","volume":"34","author":"J Knoferle","year":"2014","unstructured":"Knoferle, J. et al. Apolipoprotein E4 produced in GABAergic interneurons causes learning and memory deficits in mice. J. Neurosci. 34, 14069\u201314078 (2014).","journal-title":"J. Neurosci."},{"key":"122_CR36","doi-asserted-by":"crossref","first-page":"4050","DOI":"10.1523\/JNEUROSCI.20-11-04050.2000","volume":"20","author":"L Mucke","year":"2000","unstructured":"Mucke, L. et al. High-level neuronal expression of A\u03b21\u201342 in wild-type human amyloid protein precursor transgenic mice: synaptotoxicity without plaque formation. J. Neurosci. 20, 4050\u20134058 (2000).","journal-title":"J. Neurosci."},{"key":"122_CR37","doi-asserted-by":"crossref","first-page":"4803","DOI":"10.1523\/JNEUROSCI.0033-12.2012","volume":"32","author":"N Bien-Ly","year":"2012","unstructured":"Bien-Ly, N., Gillespie, A. K., Walker, D., Yoon, S. Y. & Huang, Y. Reducing human apolipoprotein E levels attenuates age-dependent A\u03b2 accumulation in mutant human amyloid precursor protein transgenic mice. J. Neurosci. 32, 4803\u20134811 (2012).","journal-title":"J. Neurosci."},{"key":"122_CR38","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/s41591-018-0004-z","volume":"24","author":"C Wang","year":"2018","unstructured":"Wang, C. et al. Gain of toxic apolipoprotein E4 effects in human iPSC-derived neurons is ameliorated by a small-molecule structure corrector. Nat. Med. 24, 647\u2013657 (2018).","journal-title":"Nat. Med."},{"key":"122_CR39","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3233\/JAD-190474","volume":"71","author":"MJ Lennon","year":"2019","unstructured":"Lennon, M. J., Makkar, S. R., Crawford, J. D. & Sachdev, P. S. Midlife hypertension and Alzheimer\u2019s disease: a systematic review and meta-analysis. J. Alzheimers Dis. 71, 307\u2013316 (2019).","journal-title":"J. Alzheimers Dis."},{"key":"122_CR40","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/s41592-019-0470-3","volume":"16","author":"J Ho","year":"2019","unstructured":"Ho, J., Tumkaya, T., Aryal, S., Choi, H. & Claridge-Chang, A. Moving beyond P values: data analysis with estimation graphics. Nat. Methods 16, 565\u2013566 (2019).","journal-title":"Nat. Methods"},{"key":"122_CR41","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3389\/fnins.2019.00310","volume":"13","author":"SC Kharod","year":"2019","unstructured":"Kharod, S. C., Kang, S. K. & Kadam, S. D. Off-label use of bumetanide for brain disorders: an overview. Front. Neurosci. 13, 310 (2019).","journal-title":"Front. Neurosci."},{"key":"122_CR42","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1111\/epi.12620","volume":"55","author":"M Puskarjov","year":"2014","unstructured":"Puskarjov, M., Kahle, K. T., Ruusuvuori, E. & Kaila, K. Pharmacotherapeutic targeting of cation\u2013chloride cotransporters in neonatal seizures. Epilepsia 55, 806\u2013818 (2014).","journal-title":"Epilepsia"},{"key":"122_CR43","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/ejn.12424","volume":"39","author":"M T\u00f6pfer","year":"2014","unstructured":"T\u00f6pfer, M. et al. Consequences of inhibition of bumetanide metabolism in rodents on brain penetration and effects of bumetanide in chronic models of epilepsy. Eur. J. Neurosci. 39, 673\u2013687 (2014).","journal-title":"Eur. J. Neurosci."},{"key":"122_CR44","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3389\/fneur.2019.00483","volume":"10","author":"Z Gharaylou","year":"2019","unstructured":"Gharaylou, Z. et al. Longitudinal effects of bumetanide on neuro-cognitive functioning in drug-resistant epilepsy. Front. Neurol. 10, 483 (2019).","journal-title":"Front. Neurol."},{"key":"122_CR45","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/j.celrep.2019.03.099","volume":"27","author":"C Sala Frigerio","year":"2019","unstructured":"Sala Frigerio, C. et al. The major risk factors for Alzheimer\u2019s disease: age, sex, and genes modulate the microglia response to A\u03b2 plaques. Cell Rep. 27, 1293\u20131306 (2019).","journal-title":"Cell Rep."},{"key":"122_CR46","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00401-020-02200-3","volume":"140","author":"AT Nguyen","year":"2020","unstructured":"Nguyen, A. T. et al. APOE and TREM2 regulate amyloid-responsive microglia in Alzheimer\u2019s disease. Acta Neuropathol. 140, 477\u2013493 (2020).","journal-title":"Acta Neuropathol."},{"key":"122_CR47","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1002\/alz.12287","volume":"17","author":"AJ Griswold","year":"2021","unstructured":"Griswold, A. J. et al. Increased APOE \u03b54 expression is associated with the difference in Alzheimer\u2019s disease risk from diverse ancestral backgrounds. Alzheimers Dement. 17, 1179\u20131188 (2021).","journal-title":"Alzheimers Dement."},{"key":"122_CR48","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/j.sleep.2007.11.015","volume":"9","author":"RJ Caselli","year":"2008","unstructured":"Caselli, R. J. Obstructive sleep apnea, apolipoprotein E e4, and mild cognitive impairment. Sleep Med. 9, 816\u2013817 (2008).","journal-title":"Sleep Med."},{"key":"122_CR49","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1212\/WNL.0000000000003255","volume":"87","author":"L Drogos","year":"2016","unstructured":"Drogos, L. et al. Evidence of association between sleep quality and APOE \u03b54 in healthy older adults: a pilot study. Neurology 87, 1836\u20131842 (2016).","journal-title":"Neurology"},{"key":"122_CR50","doi-asserted-by":"crossref","first-page":"e0191281","DOI":"10.1371\/journal.pone.0191281","volume":"13","author":"GJ Tranah","year":"2018","unstructured":"Tranah, G. J. et al. APOE\u03b54 and slow wave sleep in older adults. PLoS ONE 13, e0191281 (2018).","journal-title":"PLoS ONE"},{"key":"122_CR51","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1212\/01.wnl.0000265818.88703.83","volume":"69","author":"D Gozal","year":"2007","unstructured":"Gozal, D., Capdevila, O. S., Kheirandish-Gozal, L. & Crabtree, V. M. APOE \u03b54 allele, cognitive dysfunction, and obstructive sleep apnea in children. Neurology 69, 243\u2013249 (2007).","journal-title":"Neurology"},{"key":"122_CR52","doi-asserted-by":"crossref","unstructured":"Listos, J. et al. The mechanisms involved in morphine addiction: an overview. Int. J. Mol. Sci. 20, 4302 (2019).","DOI":"10.3390\/ijms20174302"},{"key":"122_CR53","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.neuropharm.2008.06.054","volume":"56","author":"E Falcon","year":"2009","unstructured":"Falcon, E. & McClung, C. A. A role for the circadian genes in drug addiction. Neuropharmacology 56, 91\u201396 (2009).","journal-title":"Neuropharmacology"},{"key":"122_CR54","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1093\/hmg\/9.3.353","volume":"9","author":"H Hamanaka","year":"2000","unstructured":"Hamanaka, H. et al. Altered cholesterol metabolism in human apolipoprotein E4 knock-in mice. Hum. Mol. Genet. 9, 353\u2013361 (2000).","journal-title":"Hum. Mol. Genet."},{"key":"122_CR55","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.neuroscience.2003.10.011","volume":"124","author":"PM Sullivan","year":"2004","unstructured":"Sullivan, P. M., Mace, B. E., Maeda, N. & Schmechel, D. E. Marked regional differences of brain human apolipoprotein E expression in targeted replacement mice. Neuroscience 124, 725\u2013733 (2004).","journal-title":"Neuroscience"},{"key":"122_CR56","doi-asserted-by":"crossref","first-page":"research0048.00","DOI":"10.1186\/gb-2002-3-9-research0048","volume":"3","author":"C Workman","year":"2002","unstructured":"Workman, C. et al. A new non-linear normalization method for reducing variability in DNA microarray experiments. Genome Biol. 3, research0048.0041\u2013research0048.0016 (2002).","journal-title":"Genome Biol."},{"key":"122_CR57","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nature13973","volume":"515","author":"JH Lui","year":"2014","unstructured":"Lui, J. H. et al. Radial glia require PDGFD\u2013PDGFR\u03b2 signalling in human but not mouse neocortex. Nature 515, 264\u2013268 (2014).","journal-title":"Nature"},{"key":"122_CR58","doi-asserted-by":"crossref","first-page":"1946","DOI":"10.1093\/cercor\/bhx101","volume":"28","author":"CS Raju","year":"2018","unstructured":"Raju, C. S. et al. Secretagogin is expressed by developing neocortical GABAergic neurons in humans but not mice and increases neurite arbor size and complexity. Cereb. Cortex 28, 1946\u20131958 (2018).","journal-title":"Cereb. Cortex"},{"key":"122_CR59","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1038\/nbt.4096","volume":"36","author":"A Butler","year":"2018","unstructured":"Butler, A., Hoffman, P., Smibert, P., Papalexi, E. & Satija, R. Integrating single-cell transcriptomic data across different conditions, technologies, and species. Nat. Biotechnol. 36, 411\u2013420 (2018).","journal-title":"Nat. Biotechnol."},{"key":"122_CR60","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nature05453","volume":"445","author":"ES Lein","year":"2007","unstructured":"Lein, E. S. et al. Genome-wide atlas of gene expression in the adult mouse brain. Nature 445, 168\u2013176 (2007).","journal-title":"Nature"},{"key":"122_CR61","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1126\/science.aam8999","volume":"360","author":"AB Rosenberg","year":"2018","unstructured":"Rosenberg, A. B. et al. Single-cell profiling of the developing mouse brain and spinal cord with split-pool barcoding. Science 360, 176\u2013182 (2018).","journal-title":"Science"},{"key":"122_CR62","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.cell.2018.05.061","volume":"174","author":"DV Dijk","year":"2018","unstructured":"Dijk, D. V. et al. Recovering gene interactions from single-cell data using data diffusion. Cell 174, 716\u2013729 (2018).","journal-title":"Cell"},{"key":"122_CR63","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin, A. et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics 29, 15\u201321 (2013).","journal-title":"Bioinformatics"},{"key":"122_CR64","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","volume":"30","author":"Y Liao","year":"2014","unstructured":"Liao, Y., Smyth, G. K. & Shi, W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics 30, 923\u2013930 (2014).","journal-title":"Bioinformatics"}],"updated-by":[{"DOI":"10.1038\/s43587-021-00144-1","type":"correction","label":"Correction","source":"publisher","updated":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T00:00:00Z","timestamp":1636675200000}}],"container-title":["Nature Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43587-021-00122-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-021-00122-7","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-021-00122-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T16:50:10Z","timestamp":1670086210000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43587-021-00122-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,11]]},"references-count":64,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["122"],"URL":"https:\/\/doi.org\/10.1038\/s43587-021-00122-7","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.740966186.793589471","asserted-by":"object"}]},"ISSN":["2662-8465"],"issn-type":[{"value":"2662-8465","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,11]]},"assertion":[{"value":"13 July 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 September 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 October 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 November 2021","order":4,"name":"change_date","label":"Change Date","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Correction","order":5,"name":"change_type","label":"Change Type","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"A Correction to this paper has been published:","order":6,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"https:\/\/doi.org\/10.1038\/s43587-021-00144-1","URL":"https:\/\/doi.org\/10.1038\/s43587-021-00144-1","order":7,"name":"change_details","label":"Change Details","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Y. Huang is a cofounder and scientific advisory board member of ESCAPE Bio, GABAeron and Mederon Bio. M.S. is on the advisory board of Aria Pharmaceuticals. A pending patent application related to this work has been filed on which Y. Huang, A.T., M.S. and P.N. were listed as inventors. The other authors declare no competing financial interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}